Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

NCT03520647 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

NIH

Sponsor class

Conditions

Severe Aplastic Anemia (SAA)
Hypo-Plastic Myelodysplastic Syndrome (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Interventions

DRUG: Cyclophosphamide
OTHER: Peripheral Blood Stem Cells

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)